Opko Health Inc

Healthcare · Diagnostics & Research

1.40$ -1.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Opko Health Inc (OPK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 164 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement OPK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	298	276	296	314	263	194	255	264	250	222	223	226	229	224	211	301	428	495	545	442	386	401	329	310	180	185	238	265	179	182	174	182	174	184	150	157	152	148	124	164	588
Cost of Revenue	151	159	155	157	151	157	154	150	151	150	144	144	142	142	140	163	273	319	364	293	244	293	244	194	148	129	138	139	131	137	132	131	134	99	127	127	121	103	97	84	406
Gross Profit	147	116	123	139	95	98	101	114	99	72	79	82	87	82	71	139	155	176	182	150	142	109	85	116	31	56	99	126	48	45	42	52	40	85	23	30	30	45	27	80	182
Research & Development	25	28	27	33	32	34	33	29	31	33	37	28	30	23	22	18	18	18	19	18	18	21	18	17	19	20	33	18	19	19	22	24	29	30	31	30	30	33	29	33	125
Selling, General & Administrative	125	121	137	128	131	125	92	88	84	95	95	88	81	79	76	78	100	356	111	113	105	138	117	102	79	74	76	80	72	73	70	69	98	67	59	60	54	51	49	53	206
Total Operating Expenses	170	165	157	161	182	190	158	119	131	147	154	133	127	195	112	111	133	127	143	144	104	172	158	126	119	111	130	119	112	114	114	113	26	118	90	90	84	83	78	87	332
Operating Income	-24	-50	-42	-26	-58	-154	-43	-5.1	-33	-90	-75	-47	-39	-112	-41	27	22	49	38	5.6	38	-63	-72	-11	-88	-55	-31	7.0	-64	-69	-71	-62	14	-33	-67	-60	-54	-38	-51	-7.0	-150
Interest Expense	2.0	1.4	1.4	1.5	1.8	1.8	2.3	2.7	2.9	4.0	4.8	5.5	5.8	5.5	5.5	5.5	5.5	5.4	5.4	4.9	4.3	4.3	2.7	3.1	3.0	3.3	3.4	3.3	3.4	3.5	7.7	8.2	17	14	15	70	11	11	11	11	45
Pre-Tax Income	-34	-45	-36	-23	-67	-150	-42	3.0	-37	-101	-78	-58	-60	-108	-58	40	21	46	32	-11	31	-66	-77	-87	-126	-102	-17	-16	-78	-73	-83	-11	48	35	-73	-163	41	-47	-61	-13	-80
Income Tax Expense	-20	-31	-6.9	-11	-24	61	-1.0	2.0	-12	-28	0.8	1.1	1.8	3.4	1.2	6.0	-3.2	14	0.6	4.8	2.7	7.5	-21	15	-40	-17	1.2	3.1	6.1	-6.0	-1.4	-0.3	24	21	-5.8	-14	20	-16	-6.1	-5.0	-7.0
Net Income	-15	-14	-31	-18	-46	-214	-43	-6.2	-28	-76	-81	-60	-62	-112	-59	34	24	32	31	-16	29	-74	-55	-102	-86	-85	-18	-20	-84	-66	-82	-10	25	14	-68	-148	22	-31	-55	-8.4	-73
EBITDA	-6.3	-17	-12	4.8	-29	-117	-15	31	-10	-74	-50	-29	-30	-80	-30	68	47	71	57	14	55	-42	-46	-55	-97	-72	13	13	-49	-43	-50	22	90	73	-34	-69	76	-13	-28	15	50

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings